According to a study in Clinical Endocrinology, scientists conclude that metformin is the only insulin sensitizing agent about which there are few concerns regarding safety in women of reproductive age, but questions remain about its efficacy in management of women with PCOS. Despite the now enormous body of literature on the use of metformin for treatment of menstrual disturbances, infertility and symptoms of androgen excess, there are few clear-cut indications for treatment. In conclusion, metformin has little place in management of infertility or hirsutism in women with PCOS. Changes in diet and lifestyle remain the primary choice of management of reproductive and metabolic sequelae in overweight and obese women with PCOS.
No comments:
Post a Comment